PMC:7074424 / 995-1134 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"23","span":{"begin":111,"end":114},"obj":"Species"}],"attributes":[{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, the occurrence of frequent recombination events is a major deterrent factor toward the development of CoV-specific vaccines/drugs."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T13","span":{"begin":133,"end":138},"obj":"CHEBI:23888;CHEBI:23888"}],"text":"However, the occurrence of frequent recombination events is a major deterrent factor toward the development of CoV-specific vaccines/drugs."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":60,"end":61},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"However, the occurrence of frequent recombination events is a major deterrent factor toward the development of CoV-specific vaccines/drugs."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T14","span":{"begin":133,"end":138},"obj":"Chemical"}],"attributes":[{"id":"A14","pred":"chebi_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"However, the occurrence of frequent recombination events is a major deterrent factor toward the development of CoV-specific vaccines/drugs."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T11","span":{"begin":0,"end":139},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, the occurrence of frequent recombination events is a major deterrent factor toward the development of CoV-specific vaccines/drugs."}